NYSE American - Delayed Quote USD

Kairos Pharma, Ltd. (KAPA)

Compare
1.5000
-0.0600
(-3.85%)
At close: January 24 at 4:00:00 PM EST
1.5900
+0.09
+(6.00%)
Pre-Market: 8:36:41 AM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -1.05M
Q3'24
-1M
-800K
-600K
-400K
-200K
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

9.00
9.00 Average
1.5000 Current
9.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1--11
Avg. Estimate -0.020-0.1-0.23
Low Estimate -0.020-0.1-0.23
High Estimate -0.020-0.1-0.23
Year Ago EPS -------0.1

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1--11
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) ------0.00%

Earnings History

Currency in USD 9/30/2024
EPS Est. -0.02
EPS Actual -0.1
Difference -0.08
Surprise % -400.00%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.020-0.1-0.23
7 Days Ago -0.020-0.1-0.23
30 Days Ago -0.020-0.1-0.23
60 Days Ago -0.020-0.1-0.23
90 Days Ago -0.020-0.1-0.23

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
KAPA -------130.00%
S&P 500 9.90%11.00%14.01%13.54%

Upgrades & Downgrades

Maintains D. Boral Capital: Buy to Buy 1/22/2025
Maintains D. Boral Capital: Buy to Buy 11/14/2024
Initiated EF Hutton: Buy 10/14/2024

Related Tickers